Trials / Completed
CompletedNCT00036114
Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- All
- Age
- 55 Years – 95 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to learn if aripiprazole is safe and effective in the treatment of psychosis associated with dementia of the Alzheimer's type.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | aripiprazole |
Timeline
- Start date
- 2000-03-01
- Primary completion
- 2003-08-01
- Completion
- 2003-08-01
- First posted
- 2002-05-09
- Last updated
- 2013-11-11
Locations
41 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00036114. Inclusion in this directory is not an endorsement.